ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Rheumatologists Can Now Treat Patients Via Telemedicine

Susan Bernstein  |  January 19, 2018

SAN DIEGO—In many regions, rheumatologists are scarce, and shortfalls will only increase. Panelists in the session, Telehealth: Can It Expand the Rheumatology Workforce?, held Nov. 6 during the 2017 ACR/ARHP Annual Meeting, believe tech­nology can help bridge the gap. The more specific term, telemedicine, “refers to clinical care delivered from a distance,” said John A….

Filed under:Meeting ReportsTechnology Tagged with:ACR/ARHP Annual Meetingpatient caretelehealthtelemedicine

Autoimmune Inflammation Increases Risk of Heart Disease

Susan Bernstein  |  January 19, 2018

SAN DIEGO—It’s no secret: Autoimmune, inflammatory rheumatic disease raises a patient’s risk of cardiovascular disease (CVD). “Inflammation may affect all aspects of the cardiac structure and function,” said Rekha Mankad, MD, FACC, director of the Women’s Heart Clinic at the Mayo Clinic in Rochester, Minn. Dr. Mankad also oversees a cardio-rheumatology clinic to assess and treat…

Filed under:ConditionsMeeting Reports Tagged with:ACR/ARHP Annual MeetingautoinflammatoryCardiovascular diseaseHeart Diseasepatient care

Barbara Volcker Center Marks 20 Years of Research & Clinical Work

Catherine Kolonko  |  January 19, 2018

Although two decades have ticked by, rheumatologist Michael Lockshin, MD, MACR, still remembers the enlightening nature of many conversations he had with his curious and persistent patient Barbara Volcker, the wife of former U.S. Federal Reserve Chairman Paul Volcker. “The conversations we had at that time led to the mission of the Barbara Volcker Center,”…

Filed under:Professional TopicsProfilesResearch Rheum Tagged with:Barbara Volcker CenterResearch

Introducing ACR Beyond, the ACR’s New Education Platform

David Daikh, MD, PhD  |  January 19, 2018

Education is a vital component of what the ACR provides to rheumatology professionals around the world, and the ACR’s commitment to continually expand options to access the latest science and medical education is critical to all involved in the specialty. This dedication is reflected in the ACR’s new mission, vision and brand promise, all of…

Filed under:Career DevelopmentEducation & TrainingPresident's PerspectiveProfessional Topics Tagged with:American College of Rheumatology (ACR)Educationmedical educationonline education

Case Review: Lupus Patient with Acute Disseminating Encephalomyelitis

Teresa Sosenko, MD, Anca Musetescu, MD, PhD, Neha Gandhi, MD, Scott Friedstrom, MD, & Diana Girnita, MD, PhD  |  January 19, 2018

Systemic lupus erythematosus (SLE) is an autoimmune-mediated rheumatic disease characterized by multisystem involvement that can cause significant morbidity and mortality. Acute disseminated encephalomyelitis (ADEM) is a rare, fulminant, autoimmune-mediated, demyelinating disease involving the white matter of the central nervous system (CNS), and is considered a manifestation of neuropsychiatric lupus. Few reported cases involve SLE and…

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR/ARHP Annual MeetingbrainClinicalDiagnosisdruglab testLupusmagnetic resonance imagingMRIoutcomepatient careprednisonepsychological disorderrheumatologistrheumatologySystemic lupus erythematosusTreatmentX-ray

Skin Exam Advised Before Anti-TNF-Alpha Therapy

Rita Buckley  |  January 16, 2018

NEW YORK (Reuters Health)—Using tumor necrosis factor alpha (TNF-alpha) inhibitors for atypical dermatoses may unmask, or perhaps even worsen, cutaneous lymphoma, according to new research. “Our findings suggest that careful skin examination might be required in all patients prescribed anti-TNF-alpha agents, especially those with atypical presentations of benign skin conditions,” says Dr. Joan Guitart of…

Filed under:Drug Updates Tagged with:Anti-TNFAnti-TNF-AlphaCancercutaneous lymphomapsoriasiform dermatitisPsoriasisskinskin disease

Rheumatoid Arthritis May Confer Higher Cardiac & Infection Risks

Lorraine L. Janeczko  |  January 16, 2018

NEW YORK (Reuters Health)—Patients with rheumatoid arthritis (RA) are at increased risk of serious infections, myocardial infarction (MI) and coronary heart disease (CHD), an analysis of Medicare claims data suggests. “Higher disease activity as measured by a panel of biomarkers was associated with higher rates of hospitalized infections, MI and CHD events. These findings add…

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiomarkersCardiacCardiovascular diseaseInfectionMyocardial infarctionRheumatoid Arthritis (RA)risk

Bimekizumab Improves Joint & Skin Symptoms in PsA Patients

Michele B. Kaufman, PharmD, BCGP  |  January 16, 2018

Preliminary results from an ongoing study show that bimekizumab improves joint and skin symptoms in patients with psoriatic arthritis…

Filed under:Biologics/DMARDsDrug UpdatesResearch Rheum Tagged with:BimekizumabPsoriasispsoriatic arthritisskin

Physical Assessment of Chronic Fatigue Syndrome: It Just May Work

Lara C. Pullen, PhD  |  January 15, 2018

A recent U.K. study assessed the use of the Perrin technique to diagnose chronic fatigue syndrome based on five physical signs of disease. Overall, researchers found the accuracy of diagnosis by allied health professionals was highest when using tests for only two signs: tender coelic plexus and postural/mechanical disturbances of the thoracic spine…

Filed under:Conditions Tagged with:chronic fatigue syndromeDiagnosismyalgic encephalomyelitisPerrin technique

FDA Removes Boxed Warning for Combination Asthma Treatment

Michele B. Kaufman, PharmD, BCGP  |  January 10, 2018

Post-market clinical safety trials have indicated that medications containing both long-acting beta agonists (LABAs) and inhaled corticosteroids (ICSs) do not result in more serious asthma-related outcomes than treatment with ICSs alone…

Filed under:Drug Updates Tagged with:asthmaDrug Safetyinhaled corticosteroidslong-acting beta agonistsU.S. Food and Drug Administration (FDA)

  • « Previous Page
  • 1
  • …
  • 170
  • 171
  • 172
  • 173
  • 174
  • …
  • 331
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences